Related Experiment Videos
von Hippel-Lindau disease
V Couch1, N M Lindor, P S Karnes
1Department of Medical Genetics, Mayo Clinic Rochester, Minn. 55905, USA.
Mayo Clinic Proceedings
|March 22, 2000
Summary
Von Hippel-Lindau (VHL) disease is an inherited disorder causing tumors. This review covers VHL clinical features, diagnostics, and genetics, aiding in better management strategies.
Area of Science:
- Oncology
- Genetics
- Hereditary Cancer Syndromes
Background:
- Von Hippel-Lindau (VHL) disease is an autosomal dominant tumor predisposition syndrome.
- It is characterized by benign and malignant tumors, including retinal angiomas, hemangioblastomas, and renal cell carcinomas.
Purpose of the Study:
- To discuss the clinical features and diagnostic criteria for VHL disease.
- To provide an update on molecular genetics and genotype-phenotype correlations in VHL.
- To explore strategies for managing and treating VHL-associated tumors.
Main Methods:
- Review of clinical features and diagnostic criteria for VHL disease.
- Update on recent findings in VHL molecular genetics.
- Discussion of genotype-phenotype correlations.
Main Results:
- VHL disease presents with a range of tumors and lesions affecting various organs.
- Recent genetic findings are refining the understanding of VHL.
- Evolving genotype-phenotype correlations are emerging.
Conclusions:
- VHL disease is clinically underdiagnosed.
- Understanding VHL molecular and functional aspects is crucial for developing effective management and treatment strategies.
- Further research into genotype-phenotype correlations will improve patient care.